Core Cap Advisors, LLC Collegium Pharmaceutical, Inc Transaction History
Core Cap Advisors, LLC
- $2.64 Billion
- Q3 2025
A detailed history of Core Cap Advisors, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Core Cap Advisors, LLC holds 2,440 shares of COLL stock, worth $112,191. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,440
Previous 2,830
13.78%
Holding current value
$112,191
Previous $83,000
2.41%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
259Shares Held
37.6MCall Options Held
53.7KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$266 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.83MShares$130 Million1.63% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.39MShares$110 Million1.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$102 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.6MShares$73.5 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.57B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...